An influenza virus vector candidate vaccine stably expressing SARS-CoV-2 receptor-binding domain produces high and long-lasting neutralizing antibodies in mice

Viral infectious pathogens, such as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus, can cause extremely high infection rates and mortality in humans. Therefore, it is urgent to develop an effective vaccine against coronavirus and influenza virus infection. Herei...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yongzhen, Zhao, Lingcai, Li, Yingfei, Liu, Qingzheng, Deng, Lulu, Lu, Yuanlu, Zhang, Xiaoting, Li, Shengmin, Ge, Jinying, Bu, Zhigao, Ping, Jihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181763/
https://www.ncbi.nlm.nih.gov/pubmed/35714529
http://dx.doi.org/10.1016/j.vetmic.2022.109491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181763/
https://www.ncbi.nlm.nih.gov/pubmed/35714529
http://dx.doi.org/10.1016/j.vetmic.2022.109491

Ejemplares similares